An overall trend of increased PFS at week 4 compared to baseline was observed, regardless of the vaccine administered.
← all excerpts
A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and naïve non-human primates.
2
—
—
The sentences
Although higher-dose SMARRT.RSV.preF immunization led to a higher number of T-cells than the low-dose group in RSV infected NHPs, the difference did not reach statistical significance.